Best Casino Stocks To Watch For 2017


The government is about to unleash a controversial plan that will force many Americans to change the way they manage their retirement.

Dubbed the Obamacare of financial planning, this legislature is officially known as the fiduciary rule. And it has been touted as financial policy meant to serve in the best interest of investors, just like Obamacare was presented as health policy meant to serve in the best interest of uninsured Americans.

But like the Affordable Care Act, the fiduciary rule is riddled with uncertainties.


For one, the fees associated with it could and will be handed off to you, the investor

The New Rule That Will Disrupt Your Retirement

You see, the Department of Labors (DOL) fiduciary rule will require brokers who manage retirement plans to act in their clients best interest a standard that many retirees assumed was already enforced.

Best Casino Stocks To Watch For 2017: Corbus Pharmaceuticals Ho ldings, Inc.(CRBP)

Advisors’ Opinion:

  • [By Keith Speights]

    Corbus Pharmaceuticals (NASDAQ:CRBP) managed to become one of the top-performing biotech stocks on the market in 2016. Over the last 12 months, Corbus’ share price has soared 550%.

Best Casino Stocks To Watch For 2017: CNH Industrial N.V.(CNHI)

Advisors’ Opinion:

  • [By Ben Levisohn]

    I wrote bullishly about Deere (DE) back in December, and since then the stock has done…not much, gaining 4.8% to the S&P 500′s 4.1% rise. So I’ve tried to stay on top of the stock, both the bullish calls and the bearish ones–and today, I have another bear to add to the list. That would be JPMorgan’s Ann Duignan, who reiterated her Underweight rating on Deere today, as well as CNH Industrial (CNHI) and Agco (AGCO). She explains why:

Best Casino Stocks To Watch For 2017: AMAG Pharmaceuticals, Inc.(AMAG)


Advisors’ Opinion:

  • [By WWW.MONEYSHOW.COM]

    Makena is the flagship drug from AMAG Pharmaceuticals (AMAG); the drug helps reduce the risk of preterm birth.

    The company’s blood registry preserves newborn stem cells used to treat blood and immune disorders.

  • [By Lisa Levin]

    Shares of AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) were down around 36 percent to $22.95. Before the open, the issue company issued FY 2017 sales that surrounded current estimates. Also, the company announced an exclusive licensing agreement with Palatin Technologies, Inc. (NYSE: PTN) for North American rights to Rekyndatm. Raymond James downgraded AMAG Pharmaceuticals from Market Perform to Underperform.

Best Casino Stocks To Watch For 2017: Exxon Mobil Corporation(XOM)


Advisors’ Opinion:

  • [By Paul Ausick]

    The DJIA stock posting the largest daily percentage loss ahead of the close Thursday was Exxon Mobil Corp. (NYSE: XOM) which traded down about 1.94% at $84.61. The stock’s 52-week range is $72.61 to $95.55. Volume was about 15% above the daily average of around 11 million shares. The company had no specific news.

  • [By Paul Ausick]

    Exxon Mobil Corp. (NYSE: XOM), the country’s largest producer of natural gas, traded up about 0.3% at $86.92 in a 52-week range of $71.55 to $95.55.

  • [By Craig Jones]

    Alan Knuckman of Bulls-Eye Option shared with the viewers of Bloomberg Markets his bullish trading idea in Exxon Mobil Corporation (NYSE: XOM).

    He said Exxon Mobil traded flat over the last year of trade, while Dow Jones gained 25 percent and he expects it's going to catch up.

  • [By Ben Levisohn]

    On Jan. 14, I panned ExxonMobil (XOM) in my trader column, and it’s been a decent call so far.

    Getty Images


    Since the close on Jan. 13, shares of ExxonMobil have lost 5.2% including reinvested dividends, while the Energy Select SPDR ETF (XLE) has lost 4.3%. The S&P 500 has returned 4.1% during the same period.

    But Exxon is getting ready to host its analyst day tomorrow. Could that be the catalyst it needs to reverse its losses? Credit Suisse analyst Edward Westlake and team don’t think so:

    With one of the highest share of longer lived cashflows in the Majors (including the leading Integrated Downstream & Chemicals), and the ability to offset upstream decline through capital efficient shale, tiebacks, low cost greenfield e.g. Guyana, and lowest cost LNG/oil sands (helped by technology), then XOM’s free cash flow should improve…we show that if XOM can hold onto the cost savings from 2016, deliver Permian growth and maintain capex control in the legacy assets, then the unlevered fcf yield could rise toward 6.5% in the $60′s Brent. The Russell 1000 is trading around 4.8%. The historical premium is 100bps (though with a wide range given cycle). This suggests XOM shares are becoming more reasonably valued vs the SPX as they have pulled back somewhat and as management continue to deliver. However, at around $60/bbl, there would be other Majors with a wider FCF yield and faster growth coming from the pure play shale exposed names. This fcf yiel d does mean that the 3.8% dividend yield is well covered (a point XOM made last year) and XOM can grow the dividend over time. We note the dividend hike normally comes just ahead of 1Q results.


    Shares of ExxonMobil have fallen 0.5% to $81.15 at 3:06 p.m. today, while the Energy Select Sector SPDR ETF has declined 0.4% to $71.28.

  • [By WWW.KIPLINGER.COM]

    As one of the biggest energy stocks on the planet, its always worth watching Exxon Mobil Corporation (XOM). After all, as goes XOM, so goes the rest of the industry. But this quarter, the reason to watch Exxon is because of the something it doesnt do that the rest of the industry does. Namely, write down the value of assets.

  • [By Paul Ausick]

    Exxon Mobil Corp. (NYSE: XOM) traded down 0.84% at $81.61. The stock’s 52-week range is $79.67 to $95.55. Volume was about 10% below the daily average of around 11 million shares. The company had no specific news.

Leave a Reply

Your email address will not be published. Required fields are marked *